Resources from the same session
If your premenopausal patient with ER+ early breast cancer requires OFS, do you always combine it with an aromatase inhibitor? YES
Presenter: Olivia Pagani
Session: YOC boxing session
Resources:
Slides
Webcast
If your premenopausal patient with ER+ early breast cancer requires OFS, do you always combine it with an aromatase inhibitor? NO
Presenter: Matteo Lambertini
Session: YOC boxing session
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: YOC boxing session
Resources:
Webcast
Do you still think that anthracycline-based chemotherapy is needed in your clinical practice for patients with early breast cancer? YES
Presenter: Alexios Matikas
Session: YOC boxing session
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: YOC boxing session
Resources:
Webcast